Novartis (FLAREX Brand) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Novartis (FLAREX Brand) General Information
Description
A brand of eye drops in the United States. The formulation contains 0.1% of fluorometholone acetate ophthalmic suspension which is indicated for the treatment of steroid responsive inflammatory conditions of the redness, swelling, and other symptoms of eye inflammation.
Contact Information
Corporate Office
- 4056 Basel
- Switzerland
Corporate Office
- 4056 Basel
- Switzerland
Novartis (FLAREX Brand) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Novartis (FLAREX Brand) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Novartis (FLAREX Brand) FAQs
-
Where is Novartis (FLAREX Brand) headquartered?
Novartis (FLAREX Brand) is headquartered in Basel, Switzerland.
-
What industry is Novartis (FLAREX Brand) in?
Novartis (FLAREX Brand)’s primary industry is Buildings and Property.
-
Is Novartis (FLAREX Brand) a private or public company?
Novartis (FLAREX Brand) is a Private company.
-
What is Novartis (FLAREX Brand)’s current revenue?
The current revenue for Novartis (FLAREX Brand) is .
-
Who are Novartis (FLAREX Brand)’s investors?
Novartis has invested in Novartis (FLAREX Brand).
-
When was Novartis (FLAREX Brand) acquired?
Novartis (FLAREX Brand) was acquired on 24-Oct-2018.
-
Who acquired Novartis (FLAREX Brand)?
Novartis (FLAREX Brand) was acquired by Eyevance Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
